Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
References (18)
- et al.
Evaluation of poly (lactic acid) as a biodegradable drug delivery system for parenteral administration
Int. J. Pharm.
(1986) - et al.
Physiological effects of subvisible microspheres administered intravenously to beagle dogs
J. Pharm. Sci.
(1978) - et al.
Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration
J. Pharm. Sci.
(1981) Preparation and characterization of biodegradable polymeric drug carriers
In vivo release profiles of leuprolide acetate from microcapsules with polylactic acids or copoly (lactic/gly-colic) acids and in vivo degradation of these polymers
Chem. Pharm. Bull.
(1988)- et al.
Comparison of cytotoxicity between Polyester nanoparticles and solid lipid nanopartieles (SLN)
- et al.
Optimization of spraydried and - congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy
Pharm. Res.
(1991) Lipidnanopellets als Trägersystem für Arzneimittel zur peroralen Anwendung
(1990)- et al.
Production of solid lipid nanoparticles (SLN) for controlled drug delivery
There are more references available in the full text version of this article.
Cited by (538)
Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases
2024, Biomedicine and PharmacotherapyTopical delivery of nanoemulsions for skin cancer treatment
2023, Applied Materials TodayExploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review
2023, Saudi Pharmaceutical JournalA state-of-the-art review on solid lipid nanoparticles as a nanovaccines delivery system
2023, Journal of Drug Delivery Science and TechnologyUnravelling the role of solid lipid nanoparticles in drug delivery: Journey from laboratory to clinical trial
2023, Journal of Drug Delivery Science and Technology
Copyright © 1994 Published by Elsevier B.V.